| Today's Open | $44.88 |
|---|---|
| Previous Close | $45.13 |
| Daily Range | $44.85 - $45.35 |
| 52-Week Range | $31.48 - $46.90 |
| Market Cap | $2.2B |
| P/E Ratio | 21.59 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 484,903 |
| Average Daily Volume | 507,270 |
| Current FY EPS | $2.81 |
Sector
Healthcare
Industry
Drugs
Charles River Laboratories (CRL) Description
Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies. Website: http://www.criver.com/
News & Commentary
The Danger of Chasing This IPO's Profits
The largest contract research organization is back on the marketCharles River Laboratories International Management Discusses Q1 2013 Results - Earnings Call Transc
Charles River Laboratories International Management Discusses Q1 2013 Results - Earnings Call TranscriptCRL's Top Competitors
(-0.27%)
(0.07%)
(0.90%)
(0.96%)